Free Trial

Arch Therapeutics (ARTH) SEC Filings & 10K Form

Arch Therapeutics logo
$0.23 +0.02 (+8.24%)
(As of 04:18 PM ET)

Recent Arch Therapeutics SEC Filings

DateFilerForm TypeView
11/13/2024
4:18 PM
Arch Therapeutics (Subject)
Bigger Capital, LLC (Filed by)
Form SC 13G/A
11/07/2024
3:30 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
4:00 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:30 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
3:30 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
4:19 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
3:32 PM
Arch Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/16/2024
4:15 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
4:16 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
3:45 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
3:45 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
3:30 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
4:00 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
4:30 PM
Arch Therapeutics (Filer)
Form S-1/A
06/18/2024
3:30 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
3:30 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
3:36 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
3:29 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
3:31 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
4:30 PM
Arch Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/15/2024
3:30 PM
Arch Therapeutics (Filer)
Form NT 10-Q
01/22/2024
11:39 AM
Arch Therapeutics (Subject)
Parker Michael Andrew (Filed by)
Form SC 13G/A
01/12/2024
3:30 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
3:30 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
3:30 PM
Arch Therapeutics (Filer)
Form NT 10-K
12/15/2023
3:31 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
3:34 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2023
3:30 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
3:33 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:ARTH) was last updated on 11/20/2024 by MarketBeat.com Staff
From Our Partners